Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab

A 45-year-old man with allergic bronchopulmonary aspergillosis (ABPA) was treated with oral prednisolone (PSL) (30 mg/day), inhaled corticosteroids, and long-acting beta2-agonists. After confirmation of a PSL-dependent status (8 mg/day), subcutaneous injection with anti-interleukin (IL)-5 antibody (...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikura, Sunao, Saraya, Takeshi, Yoshida, Yuki, Oda, Miku, Ishida, Manabu, Honda, Kojiro, Nakamoto, Keitaro, Tamura, Masaki, Takata, Saori, Shimoyamada, Hiroaki, Fujiwara, Masachika, Ishii, Haruyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479224/
https://www.ncbi.nlm.nih.gov/pubmed/33642487
http://dx.doi.org/10.2169/internalmedicine.6679-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479224/
https://www.ncbi.nlm.nih.gov/pubmed/33642487
http://dx.doi.org/10.2169/internalmedicine.6679-20

Ejemplares similares